April 2019 – Department of Economics Universidad Carlos III

Round Table: “The Integrated Energy and Climate Plan”

Included in the events of the Master in the Industrial Economics and Markets, on April 25 at 17:00 in “Salón de Grados” in Campus of Puerta de Toledo will take place a round table in reference to the Integrated National Plan of Energy and Climate 2021-2030.

Speakers:

JOAN GROIZARD, Director of Renewable Energy and Electricity Market Institute for the Diversification and Saving of Energy (IDAE).

Discussants:

CONCEPCIÓN SÁNCHEZ (REE)

MARÍA TERESA NONAY (ENAGÁS)

RAFAEL GÓMEZ-ELVIRA (OMIE) The act will take place on April 25, 2019, at 5:00 p.m., in the Hall of Degrees of the Campus Madrid-Puerta de Toledo.

The event will take place on April 25, 2019, at 5:00 p.m., in “Salón de Grados” of the Campus Madrid-Puerta de Toledo.

Download the Invitation

Félix Lobo. President of the “Comité Asesor para la Financiación de la Prestación Farmacéutica del Sistema Nacional de Salud”

On March 22, the Council of Ministers agreed, at the proposal of the Ministry of Health, the creation of an Advisory Committee to finance the pharmaceutical provision of the National Health System (NHS). This week, the Ministry has announced the names of the people who will constitute the Committee, which will be chaired by Felix Lobo Aleu.
Ana Ortega Eslava has been named vice-president of the Advisory Committee, while Jaume Puig Junoy, Marta Trapero Bertrán, Ana Clopés Estela, Emilio Alegre del Rey and Roberto Sabrido Bermúdez have been appointed members of this committee. Membership of the Advisory Committee will always be individual and members will not receive retribution.

Advice on pricing
This committee will be in charge of providing advice, evaluation and consultation on the pertinence, improvement and follow-up of the economic evaluation necessary to support the decisions of the Inter-ministerial Committee on Drug Prices.
Among other tasks, it will advise on measures to be undertaken to improve the criteria and procedures for setting the financing prices of medicines that can be financed by the System.